Ownership and insider activity for Predictive Oncology Inc. (POAI): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline.
Price
| Price | $4.91 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.8M | $766189 | $162152 | $150831 | $678332 | $28.2M | $22.1M | $8.7M | $734673 | $10.8M |
| Short-term Investments | $284329 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $38919 | $805011 | $729878 | $297055 | $256878 | $354196 | $331196 | $277641 | $745566 | $7.3M |
| Inventory | $272208 | $265045 | $241066 | $190156 | $289535 | $387684 | $430493 | $480803 | $385728 | $24.4M |
| Total Current Assets | $2.6M | $2.4M | $1.5M | $798264 | $1.5M | $29.5M | $23.4M | $10.1M | $2.2M | $42.8M |
| Property, Plant & Equipment | $101496 | $87716 | $180453 | $2.2M | $5.2M | $3.3M | $2.0M | $4.0M | $2.4M | $1.7M |
| Goodwill | 0 | 0 | 0 | $15.7M | $2.8M | $6.9M | 0 | 0 | 0 | 0 |
| Intangible Assets | $97867 | $95356 | $964495 | $3.6M | $3.4M | $4.0M | $253865 | $252457 | $210113 | 0 |
| Total Assets | $2.8M | $3.6M | $3.7M | $22.4M | $13.1M | $43.8M | $25.7M | $14.4M | $5.0M | $52.9M |
| Accounts Payable | $220112 | $140462 | $445689 | $3.2M | $1.4M | $1.0M | $943452 | $1.3M | $1.1M | $1.8M |
| Short-term Debt | 0 | 0 | $1.6M | $5.3M | $4.4M | 0 | 0 | $150408 | 0 | $107951 |
| Total Current Liabilities | $1.6M | $932340 | $3.7M | $10.9M | $9.3M | $3.2M | $3.9M | $4.0M | $3.6M | $4.3M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.9M | $932340 | $3.7M | $11.1M | $10.4M | $3.5M | $4.0M | $6.1M | $5.2M | $5.2M |
| Retained Earnings | -$47.0M | -$54.8M | -$63.1M | -$82.5M | -$108.4M | -$128.0M | -$153.8M | -$167.8M | -$180.4M | -$413.5M |
| Total Equity | $923682 | $2.7M | $53472 | $11.2M | $2.6M | $40.3M | $21.8M | $8.3M | -$202610 | $47.7M |
| Total Debt | 0 | 0 | $1.6M | $6.0M | $5.9M | $879326 | $180319 | $2.7M | $2.1M | $1.7M |
| Net Debt | -$2.0M | -$766189 | $1.5M | $5.8M | $5.2M | -$27.3M | -$21.9M | -$6.0M | $1.4M | -$9.1M |
| Working Capital | $1.0M | $1.4M | -$2.2M | -$10.1M | -$7.8M | $26.2M | $19.5M | $6.1M | -$1.4M | $38.5M |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 1.45 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 2.62 |
Profitability
| Return on Equity | -488.50% |
| Return on Invested Capital | -57.56% |
| Return on Assets | -440.73% |
| Gross Margin | 7.15% |
| Operating Margin | -1483.87% |
| Net Margin | -7242.42% |
Related companies: AIM · AMIX · BNGO · CYCN · GBS · HSCS · KTTA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of POAI: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks